A detailed history of Mirova transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mirova holds 40,232 shares of GILD stock, worth $3.68 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
40,232
Previous 40,232 -0.0%
Holding current value
$3.68 Million
Previous $2.76 Million 22.17%
% of portfolio
0.59%
Previous 0.51%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $2.88 Million - $3.51 Million
40,232 New
40,232 $2.95 Million
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $274,472 - $313,073
-3,611 Reduced 62.48%
2,168 $167,000
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $446,774 - $509,014
5,779 New
5,779 $479,000
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $302,924 - $343,825
-4,669 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $27,888 - $30,088
412 Added 9.68%
4,669 $326,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $867,720 - $990,068
-14,462 Reduced 77.26%
4,257 $275,000
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $170,176 - $193,908
3,004 Added 19.12%
18,719 $1.09 Million
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $1,738 - $2,186
-28 Reduced 0.18%
15,715 $993,000
Q2 2020

Aug 13, 2020

BUY
$72.34 - $84.0 $236,190 - $274,260
3,265 Added 26.17%
15,743 $1.21 Million
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $325,425 - $416,823
5,196 Added 71.35%
12,478 $933,000
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $14.5 Million - $15.9 Million
-235,015 Reduced 96.99%
7,282 $473,000
Q3 2019

Nov 13, 2019

SELL
$62.51 - $69.0 $8.44 Million - $9.32 Million
-135,084 Reduced 35.8%
242,297 $15.4 Million
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $23.2 Million - $26 Million
374,438 Added 12723.0%
377,381 $25.5 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $1.37 Million - $1.54 Million
-21,927 Reduced 88.17%
2,943 $191,000
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $1.51 Million - $1.96 Million
24,870 New
24,870 $1.56 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mirova Portfolio

Follow Mirova and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.